IASST’s smart sensor to help Parkinson’s patients manage drug dosage
New Delhi, Aug 27 (IANS) Scientists at the Institute of Advanced Study in Science and Technology (IASST), an autonomous institute of the Department of Science and Technology, on Tuesday revealed a low-cost and portable smartphone-based sensor system that can assist in managing symptoms of Parkinson’s disease. People with Parkinson’s face a continuous decrease in neuron
New Delhi, Aug 27 (IANS) Scientists at the Institute of Advanced Study in Science and Technology (IASST), an autonomous institute of the Department of Science and Technology, on Tuesday revealed a low-cost and portable smartphone-based sensor system that can assist in managing symptoms of Parkinson’s disease.
People with Parkinson’s face a continuous decrease in neuron cells that reduces the levels of dopamine (neurotransmitter) in their body. L-dopa is a chemical that is converted to dopamine in our body and so acts as an anti-Parkinson’s drug.
A correct dosage of L-dopa ensures the disease remains manageable. When L-dopa decreases, Parkinson’s symptoms return. On the other hand, too much of the chemical can cause serious side effects like dyskinesia, gastritis, psychosis, paranoia, and orthostatic hypotension.
IASST’s novel optical sensor system uses a fluorescence turn-on mechanism to instantly detect low levels of L-dopa in biological samples. It also reveals the precise dosage required.
The system acts as an effective probe that “can detect L-dopa in real samples such as blood plasma, sweat, and urine within a linear range of 5 micrometre to 35 micrometre. The corresponding detection limits were determined to be 95.14 nM, 93.81 nM, and 104.04 nM, respectively,” said the researchers, in the paper published in the journal Progress in Neurobiology.
The smartphone-based electronic device comes with an electric circuit connected to a 365nm LED powered by a 5V smartphone charger.
The whole setup is immersed in a dark chamber to isolate it from external light. Visual colour changes during the sensing process were observed by illuminating the sensor probe with the 365 nm LED and capturing images with a smartphone camera.
“The RGB values from the images are used to evaluate L-dopa concentration using a mobile app. This simple, cost-effective, and rapid screening tool is crucial for on-spot analyte detection in remote areas lacking advanced equipment,” the team said.
–IANS
rvt/
Naveen Praises Determination of Ganjam Boy Who Beat All Odds to Realize Dream of Becoming a Doctor
Next Articleଠେଲାରେ ଜଳଖିଆ ବିକୁଥିଲେ… ଗାଁର ପ୍ରଥମ ଡାକ୍ତର ହେବେ: ବିରୋଧୀ ଦଳ ନେତା ନବୀନ ପଟ୍ଟନାୟକଙ୍କ ପ୍ରଶଂସା
Related Articles
New AI tool to revolutionise personalised cancer treatment

Health & LifestyleNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Researchers turn toxic fungus into potent anti-cancer compound

Health & LifestyleResearchers turn toxic fungus into potent anti-cancer compound
New Delhi: A team of US researchers has turned a deadly fungus into a potent cancer-fighting compound, according to a new study released on Monday. After isolating a new class of molecules from Aspergillus flavus — a toxic crop fungus linked to deaths in the excavations of ancient tombs — the researchers modified the chemicals
Covid-19 virus protein triggers immune attack on healthy cells: Study

Health & LifestyleCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
